Allscripts (MDRX) Reports In-Line Q2 EPS, Offers Guidance, Approves $250M Buyback

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Allscripts (MDRX) Reports In-Line Q2 EPS, Offers Guidance, Approves $250M Buyback

Allscripts announces second quarter 2018 results

August 2, 2018 4:01 PM EDT

Reported second quarter growth of 23% in GAAP revenue to $526 million, 25% in non-GAAP revenue to $536 millionSecond quarter GAAP EPS of $0.36, growth of 20% in non-GAAP EPS to $0.18Announces new $250 million stock repurchase authorization Closed acquisition of HealthGrid to expand FollowMyHealth® patient engagement platformClosed sale of OneContent; recognized gain of $178 million

CHICAGO, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) (Allscripts) announced its financial results for the three and six months ended June 30,... More